Literature DB >> 15581545

Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter?

C A van den Bosch1.   

Abstract

Malaria and Epstein-Barr virus (EBV), recognised cofactors for endemic Burkitt's lymphoma, are ubiquitous within the lymphoma belt of Africa, and, unless other cofactors are involved, the tumour should be much more common than it is. Malaria and EBV alone cannot account for the occasional shifting foci and space-time case clusters of endemic Burkitt's lymphoma. Arboviruses and plant tumour promoters are other possible local cofactors that could explain such characteristics. The geographical and age distributions of endemic Burkitt's lymphoma parallel those of potentially oncogenic, mosquito-borne arboviruses. Arboviruses seem to be associated with case clusters of endemic Burkitt's lymphoma, and symptoms compatible with arbovirus infection have been seen immediately before the onset of the tumour. RNA and DNA viruses, including EBV, are promoted by extracts of a commonly used plant, Euphorbia tirucalli, the distribution of which coincides with the boundaries of the lymphoma belt. Extracts of E tirucalli are tumour promoters and can induce the characteristic 8;14 translocation of endemic Burkitt's lymphoma in EBV-infected cell-lines. They also activate latent EBV in infected cells, enhance EBV-mediated cell transformation, and modulate EBV-specific immunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581545     DOI: 10.1016/S1470-2045(04)01650-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  34 in total

Review 1.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

3.  Acute febrile illness and a splenic mass in a 15-year-old West African immigrant.

Authors:  Jennifer Ahmed; Timothy Mailman; Joanne M Langley
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-07       Impact factor: 2.471

4.  A case of late recurrence of Burkitt's Lymphoma presenting with abdominal masses and haematemesis.

Authors:  Chin-Nam Bong; Solomon Cc Chen; Alexander David Barr; Kwongleung Yu; Tsung-Che Hsieh; Teck-Siong Tok; John A Phillips
Journal:  Malawi Med J       Date:  2007-03       Impact factor: 0.875

5.  Burkittts lymphoma revisited: series of three cases with varied clinical presentation.

Authors:  Tathagat Chatterjee; Devika Gupta; Reena Bharadwaj; Renu Madan
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-28       Impact factor: 0.900

6.  The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.

Authors:  D Lenze; L Leoncini; M Hummel; S Volinia; C G Liu; T Amato; G De Falco; J Githanga; H Horn; J Nyagol; G Ott; J Palatini; M Pfreundschuh; E Rogena; A Rosenwald; R Siebert; C M Croce; H Stein
Journal:  Leukemia       Date:  2011-06-24       Impact factor: 11.528

Review 7.  Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review.

Authors:  Chris A Rees; Elizabeth M Keating; Heather Lukolyo; Heather E Danysh; Michael E Scheurer; Parth S Mehta; Joseph Lubega; Jeremy S Slone
Journal:  Pediatr Blood Cancer       Date:  2016-04-15       Impact factor: 3.167

8.  Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited.

Authors:  Martin D Ogwang; Kishor Bhatia; Robert J Biggar; Sam M Mbulaiteye
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

9.  Antimalarial therapy prevents Myc-induced lymphoma.

Authors:  Chi V Dang
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

10.  Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda.

Authors:  Lynnette K Tumwine; Claudio Agostinelli; Cristina Campidelli; Emmanuel Othieno; Henry Wabinga; Simona Righi; Brunangelo Falini; Pier Paolo Piccaluga; Wilson Byarugaba; Stefano A Pileri
Journal:  BMC Clin Pathol       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.